about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersGenome-wide association studies identify four ER negative-specific breast cancer risk lociGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskSCCA2-like serpins mediate genetic predisposition to skin tumorsComparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patientsA large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanomaPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.Molecular genetic diagnosis of autosomal dominant polycystic kidney disease in a newborn with bilateral cystic kidneys detected prenatally and multiple skeletal malformations.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersSkeletal malformations and polycystic kidney disease.Exploring the link between MORF4L1 and risk of breast cancer.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosisCommon breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case reportComparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations.Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.Characterization of an Italian founder mutation in the RING-finger domain of BRCA1.Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersAssociations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersFine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersPathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorAssociation of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
P50
Q21144874-711B8799-78A3-4A24-B6FC-1211712B748DQ24622610-B36EC6D2-2242-48AC-B2E4-18F020D80D89Q27008356-05593442-8F3B-47BB-A862-0F178678AB57Q28191746-266387C3-2EFD-4C44-B6A0-42D39CB5CCDDQ28289611-9C289505-8B39-426C-BD39-60AA0A071FD1Q28386783-49D13930-0FB5-4405-A199-28AEC8E232AAQ28584533-73499E13-B2C0-4E2F-BBF7-479DE59053F3Q30252854-E5842302-B338-4454-A0BD-BCE4C0EB248CQ30374367-5A3DFCEA-B74B-4F61-9FC1-248BB71ACB58Q31043651-3E9BFD56-291A-4B80-AE3B-E5F7E64BDFDBQ31049299-164022F8-CE3C-4B6B-8A1B-02F1641A1BABQ33595353-5209FEA5-1026-4097-BF73-1DCECAA13F0DQ33614244-74FE525E-ABB1-40AB-9714-EB89C9836981Q33675095-A91EC819-B872-4C25-8EAC-DCD086FD495BQ33863235-D4C696C5-900C-40EF-98DD-6F43301CCA3BQ34081324-1482EAA6-AC61-4258-87BE-4D910E42CCADQ34388506-B41C0B9C-1A10-4FBF-A766-B4CC3C0A179AQ34394665-9BCECFCA-58BF-43F8-A0E3-293A80C6EFECQ34572133-CC024BD2-F4C5-4400-8907-208756662C6FQ34603197-EF55A338-EDBD-4C8A-B742-16788AE782BCQ34806825-6BA6E133-B868-4C0F-A70B-55A68CA6BCC3Q34963894-8E72340D-78DC-4777-ACB0-BCD3A0E50710Q35022825-536D70AA-3CA8-4CDC-97EF-C35BFB2E28AFQ35091400-CD7F181B-A46E-473A-ADA4-DD2482EAC897Q35242849-CE711A20-A9C4-4E38-A2B9-BD6CFE67544FQ35382206-8C586639-8158-4517-8E7F-15EBD152D103Q35523236-604A7D54-15D0-4B98-944D-C4A95A67DDDEQ35524465-E4E0481B-3518-4C58-878C-C1D8721C7B23Q35541663-5B46EA0B-775F-45AC-B135-10FCDE8413F9Q35618307-D8602846-DCA4-4EA3-993A-0602AD5801D0Q35737888-95F1D2C7-64BA-4259-A815-41428D8B0099Q35870067-BBD22C80-9D95-4081-B833-D11EFE20544BQ35889575-BC75603D-8B62-4375-9740-1E8D2D535CFDQ35940158-BC8863F7-DD87-4A8C-8084-5A2FB8A03CDBQ35957703-8A038FEC-0B56-44C9-AF08-31C966D58CCCQ35984974-680D41B5-009E-48EB-935E-1CED6CEB51D0Q35999309-830C3473-B793-4DA0-A039-0DA31559C5A0Q36072765-B5BD86FF-3769-4577-887E-24FFB7E5EE2EQ36086247-DC3E7AD1-7CC7-4439-90B6-11C377B45692Q36087170-8520E1C3-49A7-4819-9FD0-E7FF1A1AB577
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bernard Peissel
@ast
Bernard Peissel
@en
Bernard Peissel
@es
Bernard Peissel
@nl
type
label
Bernard Peissel
@ast
Bernard Peissel
@en
Bernard Peissel
@es
Bernard Peissel
@nl
altLabel
Peissel B
@en
bernard peissel
@en
prefLabel
Bernard Peissel
@ast
Bernard Peissel
@en
Bernard Peissel
@es
Bernard Peissel
@nl
P1053
E-8187-2017
P106
P1153
6603551273
P21
P31
P496
0000-0001-9233-3571